
Novo Nordisk A/S
VerifiedGlobal healthcare company with 95 years of innovation and leadership in diabetes care
Launch date
Employees
Market cap
$240.1b
Net debt
-
Firm valuation
$281.5b (Public information from Aug 2022)
Share price
$105.32 NVO
Bagsværd Capital Region of Denmark (HQ)
Deals in current and previous year:
Corporate Venture Fund: Novo Ventures, Novo Holdings
RELATED LANDSCAPES AND LISTS
Financials
EditEUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E |
---|---|---|---|---|---|---|---|
Revenues | - | 14.9b | 14.9b | 16.3b | 16.9b | 18.8b | 21.0b |
% growth | - | - | - | 9 % | 4 % | 11 % | 12 % |
EBITDA | - | 7.0b | 6.8b | 7.8b | 8.0b | 8.6b | 9.7b |
% EBITDA margin | - | 47 % | 46 % | 48 % | 47 % | 46 % | 46 % |
Profit | - | 5.1b | 5.2b | 5.2b | 5.6b | 6.4b | 6.7b |
% profit margin | - | 34 % | 35 % | 32 % | 33 % | 34 % | 32 % |
R&D budget | 2.0b | 1.9b | 1.8b | 1.7b | - | - | - |
R&D % of revenue | - | 13 % | 12 % | 11 % | - | - | - |
Source: Company fillings or news article
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - Not yet verified | |
N/A | N/A | IPO Not yet verified | |
N/A | $22m | Post IPO Equity Not yet verified | |
Total Funding | - |
Recent News about Novo Nordisk A/S
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
By Industry
Investments by Novo Nordisk A/S
Edit
ACQUISITION by Novo Nordisk A/S May 2013

ACQUISITION by Novo Nordisk A/S Nov 2020

ACQUISITION by Novo Nordisk A/S Nov 2021

exited

exited

exited

ACQUISITION by Novo Nordisk A/S Jun 2020

ACQUISITION by Novo Nordisk A/S Aug 2018